25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Biosolution Co.Ltd
Buy, Hold or Sell?

Let's analyze Biosolution Co.Ltd together

I guess you are interested in Biosolution Co.Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biosolution Co.Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Biosolution Co.Ltd

I send you an email if I find something interesting about Biosolution Co.Ltd.

1. Quick Overview

1.1. Quick analysis of Biosolution Co.Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Biosolution Co.Ltd? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩4,977.37
Expected worth in 1 year
₩4,924.07
How sure are you?
30.4%

+ What do you gain per year?

Total Gains per Share
₩-53.30
Return On Investment
-0.3%

For what price can you sell your share?

Current Price per Share
₩19,640.00
Expected price per share
₩18,300 - ₩24,050
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biosolution Co.Ltd (5 min.)




Live pricePrice per Share (EOD)
₩19,640.00

2.2. Growth of Biosolution Co.Ltd (5 min.)




Is Biosolution Co.Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$27.9m$29.5m-$1.6m-5.8%

How much money is Biosolution Co.Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$336.5k-$1m$754.9k224.3%
Net Profit Margin-24.1%-50.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Biosolution Co.Ltd (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biosolution Co.Ltd?

Welcome investor! Biosolution Co.Ltd's management wants to use your money to grow the business. In return you get a share of Biosolution Co.Ltd.

First you should know what it really means to hold a share of Biosolution Co.Ltd. And how you can make/lose money.

Speculation

The Price per Share of Biosolution Co.Ltd is ₩19,640. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biosolution Co.Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biosolution Co.Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩4,977.37. Based on the TTM, the Book Value Change Per Share is ₩-13.33 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-114.60 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biosolution Co.Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.060.0%-0.040.0%-0.140.0%-0.080.0%-0.060.0%
Usd Book Value Change Per Share0.100.0%-0.010.0%-0.080.0%-0.040.0%0.150.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.100.0%-0.010.0%-0.080.0%-0.040.0%0.150.0%
Usd Price Per Share10.90-11.64-8.44-15.02-16.63-
Price to Earnings Ratio-45.46--16.07--6.77--166.02--317.71-
Price-to-Total Gains Ratio106.82-8.62--36.66--708.71--651.19-
Price to Book Ratio3.13-3.33-2.29-3.81-4.14-
Price-to-Total Gains Ratio106.82-8.62--36.66--708.71--651.19-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share13.748
Number of shares72
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.01-0.04
Usd Total Gains Per Share-0.01-0.04
Gains per Quarter (72 shares)-0.67-3.08
Gains per Year (72 shares)-2.69-12.34
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-3-130-12-22
20-5-160-25-34
30-8-190-37-46
40-11-220-49-58
50-13-250-62-70
60-16-280-74-82
70-19-310-86-94
80-21-340-99-106
90-24-370-111-118
100-27-400-123-130

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%3.09.00.025.0%3.017.00.015.0%4.019.00.017.4%4.019.00.017.4%
Book Value Change Per Share2.02.00.050.0%5.07.00.041.7%5.015.00.025.0%7.016.00.030.4%7.016.00.030.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.023.00.0%0.00.023.00.0%
Total Gains per Share2.02.00.050.0%5.07.00.041.7%5.015.00.025.0%7.016.00.030.4%7.016.00.030.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Biosolution Co.Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--145.755-13.325+109%-114.598+179%-61.189+142%216.407-33%
Book Value Per Share--4977.3674979.3810%5268.205-6%5543.093-10%5626.340-12%
Current Ratio--0.7901.056-25%1.687-53%8.527-91%10.757-93%
Debt To Asset Ratio--0.5470.556-2%0.540+1%0.349+57%0.314+74%
Debt To Equity Ratio--1.2081.252-4%1.177+3%0.732+65%0.647+87%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--76686952400.00083481087915.000-8%120877944952.500-37%187364469011.500-59%203340773567.391-62%
Eps---85.630-59.927-30%-194.347+127%-108.718+27%-92.249+8%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--5.8226.717-13%10.513-45%20.805-72%22.091-74%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap157583896800.000+21%124927763400.000133452859650.000-6%96724739100.000+29%172146767100.000-27%190630745608.696-34%
Net Profit Margin---0.209-0.241+15%-0.500+140%-0.393+89%-0.336+61%
Operating Margin----0%-0%-0.0890%-0.0820%
Operating Ratio--0.7391.672-56%0.962-23%0.831-11%0.900-18%
Pb Ratio3.946+21%3.1283.335-6%2.291+37%3.813-18%4.140-24%
Pe Ratio-57.339-26%-45.457-16.068-65%-6.774-85%-166.022+265%-317.709+599%
Price Per Share19640.000+21%15570.00016632.500-6%12055.000+29%21455.000-27%23758.696-34%
Price To Free Cash Flow Ratio----10.7310%-1.4840%23.952-100%25.307-100%
Price To Total Gains Ratio134.747+21%106.8238.616+1140%-36.660+134%-708.705+763%-651.195+710%
Quick Ratio---0.537-100%2.663-100%12.006-100%11.477-100%
Return On Assets---0.008-0.006-26%-0.017+116%-0.011+36%-0.009+14%
Return On Equity---0.017-0.014-18%-0.038+120%-0.021+21%-0.018+3%
Total Gains Per Share--145.755-13.325+109%-114.598+179%-61.189+142%216.407-33%
Usd Book Value--27955550.00027966861.4910%29589054.479-6%31132972.787-10%31600531.484-12%
Usd Book Value Change Per Share--0.102-0.009+109%-0.080+179%-0.043+142%0.151-33%
Usd Book Value Per Share--3.4843.4860%3.688-6%3.880-10%3.938-12%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--53680866.68058436761.541-8%84614561.467-37%131155128.308-59%142338541.497-62%
Usd Eps---0.060-0.042-30%-0.136+127%-0.076+27%-0.065+8%
Usd Free Cash Flow----55467.4840%-1389825.8940%-585024.4630%-610970.6570%
Usd Market Cap110308727.760+21%87449434.38093417001.755-6%67707317.370+29%120502736.970-27%133441521.926-34%
Usd Price Per Share13.748+21%10.89911.643-6%8.439+29%15.019-27%16.631-34%
Usd Profit---480946.200-336580.442-30%-1091554.424+127%-610617.538+27%-518118.057+8%
Usd Revenue--2305236.5002198887.887+5%2023100.240+14%1820006.395+27%1813463.994+27%
Usd Total Gains Per Share--0.102-0.009+109%-0.080+179%-0.043+142%0.151-33%
 EOD+5 -2MRQTTM+13 -16YOY+17 -125Y+16 -1410Y+12 -18

3.3 Fundamental Score

Let's check the fundamental score of Biosolution Co.Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-57.339
Price to Book Ratio (EOD)Between0-13.946
Net Profit Margin (MRQ)Greater than0-0.209
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.790
Debt to Asset Ratio (MRQ)Less than10.547
Debt to Equity Ratio (MRQ)Less than11.208
Return on Equity (MRQ)Greater than0.15-0.017
Return on Assets (MRQ)Greater than0.05-0.008
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Biosolution Co.Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.761
Ma 20Greater thanMa 5017,764.500
Ma 50Greater thanMa 10017,019.000
Ma 100Greater thanMa 20015,436.900
OpenGreater thanClose19,310.000
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Biosolution Co.Ltd

Bio Solution Co.,Ltd. develops, manufactures, and sells cell therapy products worldwide. The company offers CartiLife, an autologous chondrocyte cell-based therapy for the restoration of symptomatic and structural complications caused by articular cartilage defects; KeraHeal-Allo, a thermosensitive hydrogel-type allogenic keratinocyte cell-therapy product to promote re-epithelialization of deep 2nd-degree burn wounds; and KeraHeal, an autologous spray-type keratinocyte cell-based therapy for skin wounds. It also provides reconstructed human micro-tissue models comprising KeraSkin, an epidermis model; KeraSkin-FT, a full-thickness skin model; KeraSkin-M, a pigmented skin model; corneal models; SoluAirway, a airway mucosa model; SoluOral, an oral mucosa model; SoluDPNeuron, a dopaminergic neuron model; SoluDANeuron, an islet model; and SoluLiver, a liver model. In addition, the company provides human-derived primary cell cultures and primary cells for in vitro research; bio advanced materials; and cosmetics raw materials. The company was formerly known as MCTT Bio Co., Ltd. and changed its name to Bio Solution Co.,Ltd. in January 2016. Bio Solution Co.,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-12-09 22:50:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Biosolution Co.Ltd earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Biosolution Co.Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -20.9% means that ₩-0.21 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biosolution Co.Ltd:

  • The MRQ is -20.9%. The company is making a huge loss. -2
  • The TTM is -24.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-20.9%TTM-24.1%+3.2%
TTM-24.1%YOY-50.0%+25.9%
TTM-24.1%5Y-39.3%+15.3%
5Y-39.3%10Y-33.6%-5.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-20.9%-109.0%+88.1%
TTM-24.1%-220.8%+196.7%
YOY-50.0%-207.5%+157.5%
5Y-39.3%-350.0%+310.7%
10Y-33.6%-473.2%+439.6%
4.3.1.2. Return on Assets

Shows how efficient Biosolution Co.Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biosolution Co.Ltd to the Biotechnology industry mean.
  • -0.8% Return on Assets means that Biosolution Co.Ltd generated ₩-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biosolution Co.Ltd:

  • The MRQ is -0.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.8%TTM-0.6%-0.2%
TTM-0.6%YOY-1.7%+1.1%
TTM-0.6%5Y-1.1%+0.5%
5Y-1.1%10Y-0.9%-0.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.8%-11.6%+10.8%
TTM-0.6%-11.9%+11.3%
YOY-1.7%-11.2%+9.5%
5Y-1.1%-12.6%+11.5%
10Y-0.9%-14.2%+13.3%
4.3.1.3. Return on Equity

Shows how efficient Biosolution Co.Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biosolution Co.Ltd to the Biotechnology industry mean.
  • -1.7% Return on Equity means Biosolution Co.Ltd generated ₩-0.02 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biosolution Co.Ltd:

  • The MRQ is -1.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -1.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.7%TTM-1.4%-0.3%
TTM-1.4%YOY-3.8%+2.4%
TTM-1.4%5Y-2.1%+0.7%
5Y-2.1%10Y-1.8%-0.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.7%-14.3%+12.6%
TTM-1.4%-15.9%+14.5%
YOY-3.8%-14.7%+10.9%
5Y-2.1%-18.5%+16.4%
10Y-1.8%-19.2%+17.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Biosolution Co.Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Biosolution Co.Ltd is operating .

  • Measures how much profit Biosolution Co.Ltd makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biosolution Co.Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biosolution Co.Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-8.9%+8.9%
5Y-8.9%10Y-8.2%-0.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--208.0%+208.0%
TTM--316.8%+316.8%
YOY--216.9%+216.9%
5Y-8.9%-379.8%+370.9%
10Y-8.2%-480.9%+472.7%
4.3.2.2. Operating Ratio

Measures how efficient Biosolution Co.Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.74 means that the operating costs are ₩0.74 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Biosolution Co.Ltd:

  • The MRQ is 0.739. The company is efficient in keeping operating costs low. +1
  • The TTM is 1.672. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.739TTM1.672-0.933
TTM1.672YOY0.962+0.710
TTM1.6725Y0.831+0.841
5Y0.83110Y0.900-0.069
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7392.284-1.545
TTM1.6723.244-1.572
YOY0.9623.262-2.300
5Y0.8314.764-3.933
10Y0.9006.437-5.537
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Biosolution Co.Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biosolution Co.Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.79 means the company has ₩0.79 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Biosolution Co.Ltd:

  • The MRQ is 0.790. The company is just not able to pay all its short-term debts. -1
  • The TTM is 1.056. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ0.790TTM1.056-0.266
TTM1.056YOY1.687-0.631
TTM1.0565Y8.527-7.472
5Y8.52710Y10.757-2.230
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7903.569-2.779
TTM1.0563.865-2.809
YOY1.6874.644-2.957
5Y8.5275.968+2.559
10Y10.7576.209+4.548
4.4.3.2. Quick Ratio

Measures if Biosolution Co.Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biosolution Co.Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biosolution Co.Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.537-0.537
TTM0.537YOY2.663-2.127
TTM0.5375Y12.006-11.469
5Y12.00610Y11.477+0.529
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.086-3.086
TTM0.5373.384-2.847
YOY2.6634.304-1.641
5Y12.0065.954+6.052
10Y11.4776.436+5.041
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Biosolution Co.Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Biosolution Co.Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biosolution Co.Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.55 means that Biosolution Co.Ltd assets are financed with 54.7% credit (debt) and the remaining percentage (100% - 54.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biosolution Co.Ltd:

  • The MRQ is 0.547. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.556. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.547TTM0.556-0.009
TTM0.556YOY0.540+0.016
TTM0.5565Y0.349+0.206
5Y0.34910Y0.314+0.036
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5470.346+0.201
TTM0.5560.346+0.210
YOY0.5400.311+0.229
5Y0.3490.365-0.016
10Y0.3140.383-0.069
4.5.4.2. Debt to Equity Ratio

Measures if Biosolution Co.Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biosolution Co.Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 120.8% means that company has ₩1.21 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biosolution Co.Ltd:

  • The MRQ is 1.208. The company is able to pay all its debts with equity. +1
  • The TTM is 1.252. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.208TTM1.252-0.044
TTM1.252YOY1.177+0.076
TTM1.2525Y0.732+0.520
5Y0.73210Y0.647+0.085
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2080.393+0.815
TTM1.2520.432+0.820
YOY1.1770.387+0.790
5Y0.7320.453+0.279
10Y0.6470.498+0.149
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Biosolution Co.Ltd generates.

  • Above 15 is considered overpriced but always compare Biosolution Co.Ltd to the Biotechnology industry mean.
  • A PE ratio of -45.46 means the investor is paying ₩-45.46 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biosolution Co.Ltd:

  • The EOD is -57.339. Based on the earnings, the company is expensive. -2
  • The MRQ is -45.457. Based on the earnings, the company is expensive. -2
  • The TTM is -16.068. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-57.339MRQ-45.457-11.882
MRQ-45.457TTM-16.068-29.389
TTM-16.068YOY-6.774-9.295
TTM-16.0685Y-166.022+149.953
5Y-166.02210Y-317.709+151.687
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-57.339-2.088-55.251
MRQ-45.457-2.565-42.892
TTM-16.068-3.166-12.902
YOY-6.774-3.244-3.530
5Y-166.022-6.006-160.016
10Y-317.709-6.718-310.991
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biosolution Co.Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-10.731+10.731
TTM-10.731YOY-1.484-9.247
TTM-10.7315Y23.952-34.683
5Y23.95210Y25.307-1.356
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--3.295+3.295
TTM-10.731-3.674-7.057
YOY-1.484-4.477+2.993
5Y23.952-8.054+32.006
10Y25.307-9.225+34.532
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Biosolution Co.Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.13 means the investor is paying ₩3.13 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Biosolution Co.Ltd:

  • The EOD is 3.946. Based on the equity, the company is fair priced.
  • The MRQ is 3.128. Based on the equity, the company is fair priced.
  • The TTM is 3.335. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.946MRQ3.128+0.818
MRQ3.128TTM3.335-0.206
TTM3.335YOY2.291+1.044
TTM3.3355Y3.813-0.478
5Y3.81310Y4.140-0.327
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.9461.866+2.080
MRQ3.1282.055+1.073
TTM3.3352.392+0.943
YOY2.2912.453-0.162
5Y3.8133.716+0.097
10Y4.1404.373-0.233
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Operating Income  -1,197,425-274,760-1,472,185115,034-1,357,151-1,264,633-2,621,7844,698,8292,077,045



6.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets88,177,311
Total Liabilities48,240,811
Total Stockholder Equity39,936,501
 As reported
Total Liabilities 48,240,811
Total Stockholder Equity+ 39,936,501
Total Assets = 88,177,311

Assets

Total Assets88,177,311
Total Current Assets36,211,262
Long-term Assets51,966,049
Total Current Assets
Total Current Assets  (as reported)36,211,262
Total Current Assets  (calculated)0
+/- 36,211,262
Long-term Assets
Long-term Assets  (as reported)51,966,049
Long-term Assets  (calculated)0
+/- 51,966,049

Liabilities & Shareholders' Equity

Total Current Liabilities45,861,487
Long-term Liabilities2,379,324
Total Stockholder Equity39,936,501
Total Current Liabilities
Total Current Liabilities  (as reported)45,861,487
Total Current Liabilities  (calculated)0
+/- 45,861,487
Long-term Liabilities
Long-term Liabilities  (as reported)2,379,324
Long-term Liabilities  (calculated)0
+/- 2,379,324
Total Stockholder Equity
Total Stockholder Equity (as reported)39,936,501
Total Stockholder Equity (calculated)0
+/- 39,936,501
Other
Common Stock Shares Outstanding 8,024
Net Working Capital -9,650,225



6.3. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
> Total Assets 
52,865,195
53,977,422
53,970,447
52,143,534
51,807,476
51,777,259
50,160,825
49,730,902
49,798,246
50,213,022
49,807,880
95,897,500
94,403,952
95,222,672
94,020,246
93,881,339
91,730,551
91,940,330
90,204,284
89,708,343
92,407,946
89,404,124
88,177,311
88,177,31189,404,12492,407,94689,708,34390,204,28491,940,33091,730,55193,881,33994,020,24695,222,67294,403,95295,897,50049,807,88050,213,02249,798,24649,730,90250,160,82551,777,25951,807,47652,143,53453,970,44753,977,42252,865,195
   > Total Current Assets 
48,486,251
48,934,225
48,346,871
46,604,675
44,792,853
44,111,501
42,175,114
41,611,830
40,687,362
41,244,283
40,900,731
88,188,376
87,055,200
85,777,811
83,943,150
83,218,308
79,158,848
79,764,054
77,830,826
78,129,505
44,299,113
42,415,651
36,211,262
36,211,26242,415,65144,299,11378,129,50577,830,82679,764,05479,158,84883,218,30883,943,15085,777,81187,055,20088,188,37640,900,73141,244,28340,687,36241,611,83042,175,11444,111,50144,792,85346,604,67548,346,87148,934,22548,486,251
       Cash And Cash Equivalents 
2,774,374
2,384,964
1,737,667
718,209
1,509,886
1,492,238
14,560,191
2,327,637
3,392,704
3,609,584
3,455,480
25,965,646
28,956,258
0
0
0
13,443,558
43,388,292
40,665,241
37,704,925
5,485,710
8,251,026
0
08,251,0265,485,71037,704,92540,665,24143,388,29213,443,55800028,956,25825,965,6463,455,4803,609,5843,392,7042,327,63714,560,1911,492,2381,509,886718,2091,737,6672,384,9642,774,374
       Short-term Investments 
18,000,000
0
18,000,000
7,000,000
0
0
0
33,979,235
32,811,700
32,812,500
32,811,950
56,970,880
54,127,367
78,805,508
76,461,775
75,271,421
59,356,513
30,326,513
30,921,770
34,112,562
32,224,042
25,700,104
0
025,700,10432,224,04234,112,56230,921,77030,326,51359,356,51375,271,42176,461,77578,805,50854,127,36756,970,88032,811,95032,812,50032,811,70033,979,2350007,000,00018,000,000018,000,000
       Net Receivables 
2,849,928
3,575,158
3,837,638
4,384,343
3,572,810
3,141,402
2,992,612
3,572,142
2,802,763
3,022,297
2,764,491
3,652,624
2,318,263
2,193,903
2,509,382
4,028,162
4,013,590
3,439,433
3,771,832
3,901,951
4,031,888
2,760,800
0
02,760,8004,031,8883,901,9513,771,8323,439,4334,013,5904,028,1622,509,3822,193,9032,318,2633,652,6242,764,4913,022,2972,802,7633,572,1422,992,6123,141,4023,572,8104,384,3433,837,6383,575,1582,849,928
       Inventory 
692,973
703,249
574,820
656,256
529,814
956,240
1,272,323
1,470,891
1,328,130
1,333,122
1,398,524
1,202,903
1,202,775
1,197,169
1,282,582
1,309,227
1,466,168
1,829,637
1,826,894
1,416,648
1,513,698
1,874,350
0
01,874,3501,513,6981,416,6481,826,8941,829,6371,466,1681,309,2271,282,5821,197,1691,202,7751,202,9031,398,5241,333,1221,328,1301,470,8911,272,323956,240529,814656,256574,820703,249692,973
       Other Current Assets 
89,505
113,435
88,043
384,634
210,521
0
205,701
305,947
352,065
466,780
0
0
167,113
0
0
0
51,680
53,142
49,869
0
0
0
0
000049,86953,14251,680000167,11300466,780352,065305,947205,7010210,521384,63488,043113,43589,505
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,571,703
12,176,277
12,373,458
11,578,839
48,108,832
46,988,473
51,966,049
51,966,04946,988,47348,108,83211,578,83912,373,45812,176,27712,571,7030000000000000000
       Property Plant Equipment 
1,817,241
2,489,940
2,939,228
2,881,450
4,105,275
4,518,514
4,440,181
4,185,153
5,229,834
4,968,974
4,645,564
4,342,842
3,945,301
5,466,384
5,755,896
6,474,366
8,447,827
8,070,712
7,804,262
7,223,236
6,913,808
6,504,363
0
06,504,3636,913,8087,223,2367,804,2628,070,7128,447,8276,474,3665,755,8965,466,3843,945,3014,342,8424,645,5644,968,9745,229,8344,185,1534,440,1814,518,5144,105,2752,881,4502,939,2282,489,9401,817,241
       Long Term Investments 
0
1,076,971
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000001,076,9710
       Intangible Assets 
824,960
807,633
871,996
966,061
1,139,264
1,319,738
1,739,476
2,139,303
2,112,262
2,208,162
2,452,466
2,615,311
2,643,535
2,752,619
3,072,006
3,048,663
3,097,528
3,078,342
3,199,392
3,181,998
3,349,056
3,421,647
0
03,421,6473,349,0563,181,9983,199,3923,078,3423,097,5283,048,6633,072,0062,752,6192,643,5352,615,3112,452,4662,208,1622,112,2622,139,3031,739,4761,319,7381,139,264966,061871,996807,633824,960
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
0
0
0
0
0000-1000000000000000000
> Total Liabilities 
3,801,892
4,006,753
4,214,750
3,671,872
3,710,866
3,743,662
2,704,575
2,318,635
3,134,033
3,593,595
3,435,967
47,340,137
49,390,986
51,338,511
49,978,115
51,695,568
47,955,452
49,185,057
49,840,118
50,791,349
50,217,819
50,637,108
48,240,811
48,240,81150,637,10850,217,81950,791,34949,840,11849,185,05747,955,45251,695,56849,978,11551,338,51149,390,98647,340,1373,435,9673,593,5953,134,0332,318,6352,704,5753,743,6623,710,8663,671,8724,214,7504,006,7533,801,892
   > Total Current Liabilities 
1,818,915
1,799,369
2,101,123
2,427,927
2,811,746
2,804,317
1,985,254
1,506,897
2,020,660
2,571,517
2,472,318
46,445,310
48,860,848
49,732,417
48,286,053
49,922,691
45,852,577
46,189,640
47,816,738
48,824,767
47,055,085
47,608,953
45,861,487
45,861,48747,608,95347,055,08548,824,76747,816,73846,189,64045,852,57749,922,69148,286,05349,732,41748,860,84846,445,3102,472,3182,571,5172,020,6601,506,8971,985,2542,804,3172,811,7462,427,9272,101,1231,799,3691,818,915
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30,850,501
31,623,552
32,415,972
33,228,250
34,060,881
34,914,376
0
034,914,37634,060,88133,228,25032,415,97231,623,55230,850,5010000000000000000
       Accounts payable 
226,299
173,603
144,006
371,295
98,929
0
316,185
280,916
195,365
414,428
0
0
0
0
0
0
173,091
533,225
433,843
219,936
278,137
607,327
0
0607,327278,137219,936433,843533,225173,091000000414,428195,365280,916316,185098,929371,295144,006173,603226,299
       Other Current Liabilities 
1,460,504
1,499,984
1,098,200
1,174,989
1,937,124
0
1,220,190
943,894
878,292
1,190,046
0
0
0
0
0
0
1
0
-1
0
0
0
0
0000-1010000001,190,046878,292943,8941,220,19001,937,1241,174,9891,098,2001,499,9841,460,504
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,102,874
2,995,417
2,023,379
1,966,582
3,162,735
3,028,154
2,379,324
2,379,3243,028,1543,162,7351,966,5822,023,3792,995,4172,102,8740000000000000000
       Long term Debt Total 
0
0
0
166,527
150,490
134,222
145,420
132,323
653,009
458,120
261,058
62,396
46,600
995,138
928,898
863,715
1,345,476
2,027,603
934,502
0
0
0
0
0000934,5022,027,6031,345,476863,715928,898995,13846,60062,396261,058458,120653,009132,323145,420134,222150,490166,527000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,287,472
2,052,362
1,938,177
1,689,094
1,611,368
1,350,693
0
01,350,6931,611,3681,689,0941,938,1772,052,3622,287,4720000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
0
0
1
1
0
01100-100000000000000000
       Deferred Long Term Liability 
150,015
137,514
125,013
112,511
292,114
483,258
887,783
1,297,244
1,281,800
1,435,476
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000001,435,4761,281,8001,297,244887,783483,258292,114112,511125,013137,514150,015
> Total Stockholder Equity
49,063,303
49,970,670
49,755,697
48,471,662
48,096,610
48,033,597
47,456,250
47,412,267
46,664,213
46,619,427
46,371,913
48,557,363
45,012,966
43,884,160
44,042,131
42,185,772
43,775,099
42,755,274
40,364,166
38,916,995
42,190,127
38,767,017
39,936,501
39,936,50138,767,01742,190,12738,916,99540,364,16642,755,27443,775,09942,185,77244,042,13143,884,16045,012,96648,557,36346,371,91346,619,42746,664,21347,412,26747,456,25048,033,59748,096,61048,471,66249,755,69749,970,67049,063,303
   Common Stock
3,923,563
3,991,188
3,991,188
4,017,788
4,017,788
4,045,713
4,045,713
4,045,713
4,045,713
4,045,713
4,045,713
4,054,213
4,054,213
4,071,713
4,071,713
4,071,713
4,071,713
4,071,713
4,071,713
0
0
0
0
00004,071,7134,071,7134,071,7134,071,7134,071,7134,071,7134,054,2134,054,2134,045,7134,045,7134,045,7134,045,7134,045,7134,045,7134,017,7884,017,7883,991,1883,991,1883,923,563
   Retained Earnings Total Equity00000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000
   Capital Surplus 
0
0
0
56,784,401
56,784,401
57,264,976
57,274,898
57,284,819
57,294,741
57,304,447
57,085,093
57,281,575
57,281,575
57,686,762
61,633,176
63,929,372
63,929,372
63,929,372
63,929,372
0
0
0
0
000063,929,37263,929,37263,929,37263,929,37261,633,17657,686,76257,281,57557,281,57557,085,09357,304,44757,294,74157,284,81957,274,89857,264,97656,784,40156,784,401000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
519,355
349,248
349,248
306,391
306,391
203,266
213,188
223,110
233,031
242,737
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000242,737233,031223,110213,188203,266306,391306,391349,248349,248519,355



6.4. Balance Sheets

Currency in KRW. All numbers in thousands.




6.5. Cash Flows

Currency in KRW. All numbers in thousands.




6.6. Income Statements

Currency in KRW. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue12,461,714
Cost of Revenue-4,341,370
Gross Profit8,120,3458,120,345
 
Operating Income (+$)
Gross Profit8,120,345
Operating Expense-17,493,628
Operating Income-5,031,913-9,373,283
 
Operating Expense (+$)
Research Development4,335,409
Selling General Administrative3,321,546
Selling And Marketing Expenses0
Operating Expense17,493,6287,656,956
 
Net Interest Income (+$)
Interest Income3,134,621
Interest Expense-3,261,199
Other Finance Cost-0
Net Interest Income-126,578
 
Pretax Income (+$)
Operating Income-5,031,913
Net Interest Income-126,578
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-1,249,012-5,031,913
EBIT - interestExpense = -3,261,199
-1,249,012
2,012,186
Interest Expense3,261,199
Earnings Before Interest and Taxes (EBIT)02,012,186
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-1,249,012
Tax Provision-0
Net Income From Continuing Ops-1,249,012-1,249,012
Net Income-1,249,012
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0126,578
 

Technical Analysis of Biosolution Co.Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biosolution Co.Ltd. The general trend of Biosolution Co.Ltd is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biosolution Co.Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biosolution Co.Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 23,250 < 24,050.

The bearish price targets are: 18,770 > 18,420 > 18,300.

Tweet this
Biosolution Co.Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biosolution Co.Ltd. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biosolution Co.Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biosolution Co.Ltd. The current macd is 831.35.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biosolution Co.Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Biosolution Co.Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Biosolution Co.Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Biosolution Co.Ltd Daily Moving Average Convergence/Divergence (MACD) ChartBiosolution Co.Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biosolution Co.Ltd. The current adx is 30.12.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Biosolution Co.Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Biosolution Co.Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biosolution Co.Ltd. The current sar is 16,817.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Biosolution Co.Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biosolution Co.Ltd. The current rsi is 62.76. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Biosolution Co.Ltd Daily Relative Strength Index (RSI) ChartBiosolution Co.Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biosolution Co.Ltd. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biosolution Co.Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Biosolution Co.Ltd Daily Stochastic Oscillator ChartBiosolution Co.Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biosolution Co.Ltd. The current cci is 96.23.

Biosolution Co.Ltd Daily Commodity Channel Index (CCI) ChartBiosolution Co.Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biosolution Co.Ltd. The current cmo is 28.24.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Biosolution Co.Ltd Daily Chande Momentum Oscillator (CMO) ChartBiosolution Co.Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biosolution Co.Ltd. The current willr is -15.63786008.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Biosolution Co.Ltd Daily Williams %R ChartBiosolution Co.Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biosolution Co.Ltd.

Biosolution Co.Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biosolution Co.Ltd. The current atr is 990.88.

Biosolution Co.Ltd Daily Average True Range (ATR) ChartBiosolution Co.Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biosolution Co.Ltd. The current obv is 4,547,895.

Biosolution Co.Ltd Daily On-Balance Volume (OBV) ChartBiosolution Co.Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biosolution Co.Ltd. The current mfi is 77.46.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Biosolution Co.Ltd Daily Money Flow Index (MFI) ChartBiosolution Co.Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biosolution Co.Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-08-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-24MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-16MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-12-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-17STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Biosolution Co.Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biosolution Co.Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.761
Ma 20Greater thanMa 5017,764.500
Ma 50Greater thanMa 10017,019.000
Ma 100Greater thanMa 20015,436.900
OpenGreater thanClose19,310.000
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Biosolution Co.Ltd with someone you think should read this too:
  • Are you bullish or bearish on Biosolution Co.Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biosolution Co.Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biosolution Co.Ltd

I send you an email if I find something interesting about Biosolution Co.Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Biosolution Co.Ltd.

Receive notifications about Biosolution Co.Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.